Exchange: NYSE·Updated 07:30 PM EDT

HAE News

News
all
press releases
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
More News
HAE, PCRX Stocks Hit Multi-Year Highs Amid Broader Market Selloff – What’s Driving The Momentum Today?
Pacira BioSciences secured a $1.65 billion buyout deal with Viatris, while Haemonetics expanded its CSL Plasma partnership, prompting BTIG to raise its price target.
Stocktwits
Haemonetics Stock Hits 52-Week High - Here's Why
Haemonetics stock hits a new 52-week high after CSL Plasma outlines a sweeping rollout of its technology across existing U.S. centers.read more...
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profound Medical (NASDAQ:PROF) shares moved upwards by 21.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $207.5 million. Haemonetics (NYSE:HAE) stock moved upwardsread more...
Benzinga
PAHC vs. HAE: Which Stock Is the Better Value Option?
PAHC vs. HAE: Which Stock Is the Better Value Option?
Zacks
Haemonetics Q1 2027 Earnings Call Transcript
Haemonetics (NYSE:HAE) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access toread more...
Benzinga
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026 Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026PR NewswireBOSTON, Sept. 30, 2026BOSTON, Sept. 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE...
PR Newswire
Haemonetics (HAE) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
PAHC vs. HAE: Which Stock Is the Better Value Option?
Zacks
HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?
Haemonetics and Twist Bioscience stocks surged to more than five-year highs on Thursday, as fresh growth opportunities drew cheer from Wall Street.
Stocktwits

Advertisement|Remove ads.